Frontiers in Chemistry (Jan 2022)

IR780 Based Sonotherapeutic Nanoparticles to Combat Multidrug-Resistant Bacterial Infections

  • Biying Huang,
  • Biying Huang,
  • Long Wang,
  • Long Wang,
  • Long Wang,
  • Long Wang,
  • Kui Tang,
  • Kui Tang,
  • Sijie Chen,
  • Sijie Chen,
  • Yan Xu,
  • Yan Xu,
  • Haiqin Liao,
  • Haiqin Liao,
  • Chengcheng Niu,
  • Chengcheng Niu

DOI
https://doi.org/10.3389/fchem.2022.840598
Journal volume & issue
Vol. 10

Abstract

Read online

Multidrug-resistant (MDR) bacterial strains have emerged and weakened the therapeutic effects of antibacterial drugs. Sonodynamic therapy (SDT) takes advantage of noninvasiveness and deep tissue-penetrating features and has been rejuvenated to combat MDR bacteria and their biofilm-associated infections. To improve the efficacy of antibacterial SDT, we first developed IR780-based PLGA nanoparticles as sonosensitizers for high-frequency ultrasound (US)-monitored antibacterial SDT of MRSA myositis by therapeutic low-frequency US. In this study, the developed shell-core-structured IR780@PLGA nanoparticles were designed with a polymer shell PLGA with the sonosensitizer IR780 loaded on. High-frequency diagnostic US was introduced to monitor the sonotherapeutic progression of bacterial myositis by therapeutic low-frequency US. Importantly, the in vitro and in vivo results confirmed that IR780@PLGA nanoparticles combined with US irradiation possess high efficiency for antibacterial therapy. This approach provides a simple and efficient strategy to monitor and combat MDR bacterial infection.

Keywords